RE: Delay-Delay-Delay....
I think you are missing the point. A Catalyst victory will result in a substantial amount of investment in Hemosol to bring it to commercial production. Catalyst has the access to capital to do this, AND attract alot of attention.
PLI has to be an integral part of this renewal. Catalyst will want to ensure its future through some kind of substantial arrangement with Prometic. This could be as simple as a long term supply contract, or as complex as the formation of a JV company jointly owned by Prometic and Catalyst. Both GREAT for Prometic.
At the very least, this situation will mean up front cash, or equivalent value for Prometic short term. Medium term, it will become a SUBSTANTIAL revenue stream for Prometic and a showcase for the technology. Ironically, this is what we hoped Hemosol would do, but the market never "bought it" because Hemosol couldnt raise capital as a fallen angel. CATALYST CAN... and as the likelihood of this all developing becomes clearer, the market WILL PAY ....all of which substantially increases the value of Prometic's franchise.